Correction: Risk Factors for Visceral Leishmaniasis Relapse in Immunocompetent Patients following Treatment with 20 mg/kg Liposomal Amphotericin B (Ambisome) in Bihar, India

Bibliographic Details
Main Author:	The Staff
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2014-04-01
Series:	PLoS Neglected Tropical Diseases
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3976243/?tool=EBI

id	doaj-167a2f911a0d403c8b464c73bc33e58c
record_format	Article
spelling	doaj-167a2f911a0d403c8b464c73bc33e58c2021-03-03T08:31:16ZengPublic Library of Science (PLoS)PLoS Neglected Tropical Diseases1935-27271935-27352014-04-0184Correction: Risk Factors for Visceral Leishmaniasis Relapse in Immunocompetent Patients following Treatment with 20 mg/kg Liposomal Amphotericin B (Ambisome) in Bihar, IndiaThe Staffhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3976243/?tool=EBI
collection	DOAJ
language	English
format	Article
sources	DOAJ
author	The Staff
spellingShingle	The Staff Correction: Risk Factors for Visceral Leishmaniasis Relapse in Immunocompetent Patients following Treatment with 20 mg/kg Liposomal Amphotericin B (Ambisome) in Bihar, India PLoS Neglected Tropical Diseases
author_facet	The Staff
author_sort	The Staff
title	Correction: Risk Factors for Visceral Leishmaniasis Relapse in Immunocompetent Patients following Treatment with 20 mg/kg Liposomal Amphotericin B (Ambisome) in Bihar, India
title_short	Correction: Risk Factors for Visceral Leishmaniasis Relapse in Immunocompetent Patients following Treatment with 20 mg/kg Liposomal Amphotericin B (Ambisome) in Bihar, India
title_full	Correction: Risk Factors for Visceral Leishmaniasis Relapse in Immunocompetent Patients following Treatment with 20 mg/kg Liposomal Amphotericin B (Ambisome) in Bihar, India
title_fullStr	Correction: Risk Factors for Visceral Leishmaniasis Relapse in Immunocompetent Patients following Treatment with 20 mg/kg Liposomal Amphotericin B (Ambisome) in Bihar, India
title_full_unstemmed	Correction: Risk Factors for Visceral Leishmaniasis Relapse in Immunocompetent Patients following Treatment with 20 mg/kg Liposomal Amphotericin B (Ambisome) in Bihar, India
title_sort	correction: risk factors for visceral leishmaniasis relapse in immunocompetent patients following treatment with 20 mg/kg liposomal amphotericin b (ambisome) in bihar, india
publisher	Public Library of Science (PLoS)
series	PLoS Neglected Tropical Diseases
issn	1935-2727 1935-2735
publishDate	2014-04-01
url	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3976243/?tool=EBI
work_keys_str_mv	AT thestaff correctionriskfactorsforvisceralleishmaniasisrelapseinimmunocompetentpatientsfollowingtreatmentwith20mgkgliposomalamphotericinbambisomeinbiharindia
_version_	1714826475563122688

Correction: Risk Factors for Visceral Leishmaniasis Relapse in Immunocompetent Patients following Treatment with 20 mg/kg Liposomal Amphotericin B (Ambisome) in Bihar, India

Similar Items